# Regulatory Documentation Standards

## Executive Summary

This document establishes comprehensive documentation standards for healthcare technology products, ensuring compliance with FDA, HIPAA, ONC (Office of the National Coordinator), and other regulatory frameworks. All healthcare software must adhere to these standards before deployment.

---

## 1. FDA Regulatory Framework

### 1.1 FDA Classification of Healthcare Software

#### Device Classification Structure

**Class I: General Controls**
- Low-risk devices (e.g., patient education apps)
- Regulatory pathway: 510(k) Exempt
- Examples: Medication reminder apps, general health tracking
- Documentation: Labeling, adverse event reporting

**Class II: General + Special Controls**
- Moderate-risk devices (e.g., standalone software for vital sign analysis)
- Regulatory pathway: 510(k) Substantial Equivalence
- Examples: Clinical decision support, EHR systems
- Documentation: Design specification, validation, clinical testing

**Class III: Pre-Market Approval (PMA)**
- High-risk devices (e.g., software controlling drug delivery, diagnostic decision-making)
- Regulatory pathway: PMA - requires clinical data
- Examples: Autonomous insulin pumps, AI diagnostic devices
- Documentation: Clinical data, post-market surveillance plan

#### Device Classification Decision Tree

```
Is it software?
├── Yes: Is it intended for healthcare use?
│   ├── No: Not FDA regulated
│   └── Yes: What is the intended use?
│       ├── General wellness: 510(k) Exempt (Class I)
│       ├── Clinical support/analysis: Likely Class II (510(k))
│       ├── Autonomous patient treatment: Likely Class III (PMA)
│       └── Is there an FDA-cleared predicate device?
│           ├── Yes: Class II likely
│           └── No: Class III or exemption review required
```

### 1.2 Software as a Medical Device (SaMD) Framework

**FDA IMDRF Guidelines for SaMD:**

```
SaMD RISK ASSESSMENT MATRIX:

                    NON-SERIOUS    SERIOUS         CRITICAL
IMPACT:             CONDITION      CONDITION       CONDITION

Direct Treatment   Class I/II       Class II/III    Class III
(decisions made
by autonomous
system)

Support Treatment  Class I/II       Class II        Class II/III
(clinician
oversight)

Monitoring         Class I/II       Class II        Class II
(data analysis
only)

Wellness           Class I          Class I/II      N/A
(no medical
diagnosis)

Decision Framework:
1. What is the software intended to do?
2. Who is the user? (Patient, clinician, administrator)
3. What is the severity of harm if it fails?
4. Does it require real-time autonomous decision-making?
5. Is there a cleared predicate device?
```

### 1.3 21 CFR Part 11: Electronic Records and Signatures

**Applicability**: All software maintaining electronic health records or clinical data

#### Core Requirements

```
REQUIREMENT                    STANDARD                    IMPLEMENTATION
────────────────────────────────────────────────────────────────────────
User Authentication            Unique user ID + password   LDAP/OAuth2 + MFA
Password Standards             Min 8 chars, complexity     Enforced by system
Audit Trail                    Complete record of all      Database with timezone
                               electronic transactions     immutable log
Data Integrity                 Prevent unauthorized        Cryptographic hashing
                               alteration                  (SHA-256 minimum)
Electronic Signature           Non-repudiation            PKI certificates
                               and authentication
System Validation              IQ/OQ/PQ testing           Third-party validation
                                                          report
Documentation                  Policies and procedures    SOP documentation
                                                          provided to inspectors
```

#### 21 CFR Part 11 Audit Trail Implementation

```python
class ElectronicRecordAuditTrail:
    """
    FDA 21 CFR Part 11 compliant audit trail
    """

    def log_transaction(self, transaction: Dict) -> None:
        """
        Log all electronic transactions per 21 CFR §11.1

        Required Fields:
        - User ID who performed action
        - Date and time (to second) with timezone
        - Type of action (create, modify, delete, authenticate)
        - Data affected (before/after values for modifications)
        - System state before/after
        """
        audit_record = {
            'timestamp': datetime.now(timezone.utc).isoformat(),
            'user_id': transaction['user_id'],
            'user_role': transaction['user_role'],
            'action_type': transaction['action_type'],
            'data_element': transaction['data_element'],
            'before_value': transaction['before_value'],
            'after_value': transaction['after_value'],
            'system_generated': transaction.get('system_generated', False),
            'source_ip': transaction['source_ip'],
            'transaction_id': self.generate_uuid(),
            'cryptographic_hash': self.compute_hash(transaction)
        }

        # Store in immutable log (append-only database)
        self.audit_log_db.insert(audit_record)

    def compute_hash(self, data: Dict) -> str:
        """
        Compute SHA-256 hash for data integrity
        """
        import hashlib
        serialized = json.dumps(data, sort_keys=True)
        return hashlib.sha256(serialized.encode()).hexdigest()
```

#### Example Audit Log Entry

```
AUDIT LOG RECORD
═════════════════════════════════════════════════════════════════════

Transaction ID:    AU-2025-001234-ABC789
Timestamp:         2025-01-15T10:30:45.123456Z (UTC)
User ID:           dr.smith@hospital.com
User Role:         Physician - Oncology
User Department:   Oncology - 3rd Floor

ACTION TYPE:       MODIFY
Data Element:      Patient Medication Order
Order ID:          MED-2025-007834

BEFORE MODIFICATION:
  - Medication: Metformin 500 mg
  - Frequency:  Twice daily
  - Quantity:   60 tablets
  - Status:     PENDING

AFTER MODIFICATION:
  - Medication: Metformin 500 mg
  - Frequency:  Once daily
  - Quantity:   30 tablets
  - Status:     PENDING

Modification Reason: Patient compliance issue - requested once daily
                     dosing per telephone call

Electronic Signature Status: SIGNED
Signature Certificate:      Dr. Smith's PKI Certificate (valid through 12/31/2025)
Signature Method:          FIPS 186-4 (ECDSA)

System Information:
  - IP Address:           192.168.1.100
  - Browser:              Mozilla Firefox 121.0
  - Operating System:     Windows 10
  - Session ID:           SESS-2025-0001-ABC789

Integrity Hash (SHA-256):  a7f3b8c9d2e1f4a6b8c9d0e1f2a3b4c5d6e7f8a9b0c1d2e3f4a5b6c7d8e9f0
Previous Record Hash:     9e8d7c6b5a4f3e2d1c0b9a8f7e6d5c4b3a2f1e0d9c8b7a6f5e4d3c2b1a9f8e
```

### 1.4 FDA Software Validation Requirements

**Software Development Process (21 CFR Part 11.30):**

```
REQUIREMENT                         STANDARD FRAMEWORK
─────────────────────────────────────────────────────────────────
Design Controls                     IEC 62304 / FDA Guidance
Software Requirements               Traceability matrix
Design Specification                Architecture documentation
Code Review & Testing               100% code coverage (critical paths)
Risk Management                     IEC 14971 (FMEA analysis)
Validation & Verification           IQ/OQ/PQ testing
Change Management                   Version control + impact analysis
Post-Market Surveillance            MDR (Medical Device Reporting)
```

#### Installation/Operational Qualification (IQ/OQ/PQ)

```
IQ (Installation Qualification):
  ✓ Verify hardware meets specification
  ✓ Verify software version matches release
  ✓ Verify all licenses installed
  ✓ Verify system databases created
  ✓ Verify security certificates loaded
  ✓ Document all installation steps with evidence

OQ (Operational Qualification):
  ✓ Test system functionality with test data
  ✓ Verify all critical functions work
  ✓ Test error handling and recovery
  ✓ Verify audit trail functionality
  ✓ Test backup and recovery procedures
  ✓ Verify performance meets specification

PQ (Performance Qualification):
  ✓ Test with representative data
  ✓ Run business processes end-to-end
  ✓ Verify output accuracy (clinical data)
  ✓ Measure performance metrics
  ✓ Document results and sign-off
```

---

## 2. HIPAA Compliance Framework

### 2.1 HIPAA Privacy Rule

**Applicability**: All systems handling Protected Health Information (PHI)

#### Core Requirements

```
REQUIREMENT                 STANDARD                    IMPLEMENTATION
──────────────────────────────────────────────────────────────────
Access Controls             Only authorized users       Role-based access control
Data Minimization           Minimum necessary PHI       Limit database queries
Confidentiality             Encryption in transit       TLS 1.2+ / AES-256
Integrity                   Prevent unauthorized        Digital signatures, hashing
                           modification
Accountability              Audit trails                Complete transaction logs
User Rights                 Access, amendment,          Patient portal for PHI access
                           deletion rights
Business Associates         Signed agreements           BAA (Business Associate Agr.)
```

#### HIPAA De-Identification Standards (Safe Harbor)

**When you can share data without HIPAA restrictions:**

```
REMOVE THESE IDENTIFIERS:
✗ Names
✗ Medical record numbers
✗ Health plan beneficiary numbers
✗ Account numbers
✗ Social Security numbers
✗ Vehicle identifiers and license plate numbers
✗ Device identifiers and serial numbers
✗ URLs and IP addresses
✗ Biometric identifiers (fingerprints)
✗ Face photographs
✗ Dates (except year) - birth, death, admission, discharge
✗ Geographic data (except state)
✗ Codes (e.g., NPI, license numbers)

SAFE DATA (can be shared):
✓ Age (years, not DOB)
✓ Pregnancy status
✓ Smoker/non-smoker status
✓ ICD/CPT codes (medical codes OK)
✓ Medication names (generic)
✓ Lab values
✓ Generic vital signs

EXAMPLE DE-IDENTIFIED RECORD:
64-year-old female (smoker) with Type 2 diabetes, admitted 2025,
discharged 2025. Chief complaint: Shortness of breath. Diagnosis:
Pneumonia (bacterial). Medications: Azithromycin 500mg BID. Labs:
WBC 11.2 (high), CRP 8.5 (elevated). Outcome: Discharged in stable
condition.
```

### 2.2 HIPAA Security Rule (45 CFR 164, Subpart C)

#### Administrative Safeguards

```
1. SECURITY MANAGEMENT PROCESS
   - Risk analysis (NIST 800-30 recommended)
   - Risk management plan
   - Sanction policy (consequences for violations)
   - Information system security monitoring

2. ASSIGNED SECURITY RESPONSIBILITY
   - Chief Privacy Officer (CPO)
   - Chief Information Security Officer (CISO)
   - Security officer duties documented

3. WORKFORCE SECURITY
   - Access controls (authentication, authorization)
   - Supervisor responsibilities
   - Termination procedures (deactivate immediately)

4. INFORMATION ACCESS MANAGEMENT
   - Access restrictions based on role
   - Minimum necessary principle
   - Emergency access procedures documented

5. SECURITY AWARENESS AND TRAINING
   - Annual HIPAA training (minimum)
   - Incident response training
   - Password management training
   - Phishing awareness
   - Documentation of all training
```

#### Physical Safeguards

```
1. FACILITY ACCESS CONTROLS
   - Physical access logs
   - Badge systems with audit trail
   - Video surveillance in server rooms
   - Visitor sign-in procedures
   - Locks on server rooms and file cabinets

2. WORKSTATION USE AND SECURITY
   - Workstation use policy (written)
   - Physical security (locked screens, cable locks)
   - Workstation configuration standards
   - Automatic logoff after inactivity (15 min recommended)

3. WORKSTATION DEVICE AND MEDIA CONTROLS
   - Inventory of computing devices
   - Disposal procedures (data destruction)
   - Reuse procedures (secure wiping)
   - Accountability for all devices

4. FACILITY DISPOSAL
   - Clean desk policy
   - Secure destruction (shred, incinerate, degauss)
   - Vendor contracts for secure disposal
   - Certificates of destruction
```

#### Technical Safeguards

```
1. ACCESS CONTROLS
   - Unique user identification (no shared logins)
   - Emergency access procedures
   - Encryption and decryption mechanisms
   - Key management procedures

2. AUDIT CONTROLS
   - Audit trails (all access logged)
   - Accountability (who did what, when)
   - Integrity verification (checksums, digital signatures)
   - Automated tools to record/examine PHI access

3. INTEGRITY CONTROLS
   - Mechanisms to verify PHI integrity
   - Checks for altered information
   - Documentation of integrity measures

4. TRANSMISSION SECURITY
   - TLS 1.2 minimum for all data in transit
   - VPN for remote access
   - Encryption of data at rest (AES-256)
   - Secure deletion procedures
```

### 2.3 HIPAA Breach Notification Rule

**If a breach is suspected:**

```
TIMELINE FOR BREACH RESPONSE:

Day 0: Breach Detected
  - Immediately notify Security Officer
  - Preserve evidence (don't delete logs)
  - Isolate affected system if necessary

Days 1-2: Initial Assessment
  - Determine scope (how many records? What PHI?)
  - Determine root cause (hacking? Lost device?)
  - Interview involved staff

Days 3-5: Risk Assessment
  - Likelihood of PHI misuse?
  - Were encryption controls in place?
  - Was data backed up/recoverable?
  - Could attacker realistically use data?

Days 5-7: Report Decision
  - If LOW RISK: Document decision, no notification required
  - If MEDIUM/HIGH RISK: Prepare breach notification

Days 7-30: Notification (if required)
  - Notify individuals (mail, email, or phone)
  - Include: What happened, what data, what to do, company contact
  - Notify media (if >500 residents in same jurisdiction)
  - Notify HHS (U.S. Department of Health & Human Services)

Documentation:
  - Keep incident report
  - Response timeline
  - Individuals notified
  - Investigation findings
  - Corrective actions taken
```

#### Breach Notification Template

```
HIPAA BREACH NOTIFICATION LETTER

Date: January 15, 2025

Dear [Patient Name]:

We are writing to inform you of a security incident that may have
affected your protected health information (PHI).

WHAT HAPPENED:
On January 12, 2025, we discovered unauthorized access to our patient
database. An attacker exploited a SQL injection vulnerability in our
appointment scheduling system.

WHAT INFORMATION WAS AFFECTED:
- Patient name
- Medical record number
- Date of birth
- Diagnoses (diabetes, hypertension)
- Current medications
- Insurance information

Note: Social Security numbers and financial account numbers were NOT
compromised (stored separately with encryption).

WHAT WE'VE DONE:
- Immediately patched the vulnerability (Jan 12, 2025)
- Encrypted all database backups
- Conducted full security audit
- Notified law enforcement (FBI)
- Enhanced monitoring systems

WHAT YOU CAN DO:
1. Monitor your credit reports (free from www.annualcreditreport.com)
2. Watch for suspicious medical bills
3. Consider credit monitoring service (we're offering 24 months free)
4. Call our hotline: 1-800-XXX-XXXX (available 24/7)

We sincerely apologize for this incident and are committed to
protecting your information.

Sincerely,
Chief Privacy Officer
[Hospital Name]
```

---

## 3. ONC Certification Standards

### 3.1 ONC Health IT Certification Program

**Certification Requirements (45 CFR 170.302-170.520):**

#### Mandatory Certification Criteria for EHR

```
FUNCTIONAL REQUIREMENTS:
┌─────────────────────────────────────────────────────────┐
│ 1. ADMINISTRATIVE & OPERATIONAL CAPABILITIES           │
│    - Clinical quality measures (CQM) reporting          │
│    - Interoperability (HL7 FHIR, CCDA)                │
│    - Security safeguards (encryption, audit trails)    │
│    - Patient portal (at least 13 functions)            │
│                                                         │
│ 2. CLINICAL DATA CAPABILITIES                         │
│    - Structured problem list (SNOMED CT)              │
│    - Structured allergy/adverse reactions             │
│    - Structured medication list (RxNorm)              │
│    - Structured vital signs (LOINC)                   │
│    - Structured lab values (LOINC)                    │
│    - Problem-medication linkage                        │
│                                                         │
│ 3. CARE COORDINATION CAPABILITIES                     │
│    - Send/receive summaries (CCDA format)            │
│    - Exchange structured data (HL7 FHIR)             │
│    - Bidirectional exchange (push/pull)               │
│    - Support certified APIs                           │
│                                                         │
│ 4. PATIENT ENGAGEMENT CAPABILITIES                   │
│    - Patient portal (view, download, transmit PHI)   │
│    - Secure messaging (patient-clinician)             │
│    - Medication refill requests                       │
│    - Appointment requests                             │
│    - Medication allergies view                        │
│                                                         │
│ 5. CYBERSECURITY & PRIVACY CAPABILITIES              │
│    - Full audit logging                              │
│    - Role-based access control                       │
│    - Encryption (transit & rest)                     │
│    - Integrity checking                              │
│    - Identification and authentication               │
│    - Vulnerability management                        │
└─────────────────────────────────────────────────────────┘
```

### 3.2 USCDI (United States Core Data for Interoperability)

**Required Data Elements for Certification:**

```
USCDI Version 3 (Effective 2025):

CORE DATA SETS:
1. Patient Demographics (name, DOB, sex, race, ethnicity)
2. Problems (active and historical)
3. Medications (active and historical)
4. Allergies (active)
5. Immunizations (complete history)
6. Laboratory Results (values and dates)
7. Vital Signs (BP, HR, RR, Temp, BMI)
8. Clinical Notes (progress notes, summaries)
9. Procedures (completed procedures)
10. Care Team Member Contact Information
11. Provenance (data source tracking)

All data must be:
- Structured using standard vocabularies
- Transmittable via FHIR API
- Available to patients via portal
- Auditable with complete access logs
```

### 3.3 API Requirements (45 CFR 170.405)

**Certified API Technology Stack:**

```
ENDPOINT REQUIREMENTS:
- Base URL: https://fhir.yourhospital.com/r4/ (HTTPS only)
- Authentication: OAuth 2.0 (RFC 6749)
- Authorization: SMART on FHIR
- Response Format: JSON (XML optional)
- Versioning: FHIR R4 minimum

REQUIRED OPERATIONS:
GET /Patient/{id}              - Retrieve patient demographics
GET /Condition?subject={id}    - Retrieve active problems
GET /Medication/{id}           - Retrieve medication details
GET /Observation?subject={id}  - Retrieve lab results
GET /Immunization?patient={id} - Retrieve immunizations

Example FHIR API Call:
────────────────────────────────────────────────────────────
GET /r4/Patient/12345 HTTP/1.1
Host: fhir.yourhospital.com
Authorization: Bearer [OAuth Token]
Accept: application/fhir+json

Response:
{
  "resourceType": "Patient",
  "id": "12345",
  "name": [{"use": "official", "given": ["John"], "family": "Smith"}],
  "birthDate": "1960-03-15",
  "gender": "male",
  "address": [{"use": "home", "state": "CA", "postalCode": "12345"}]
}
```

---

## 4. Documentation Requirements Template

### 4.1 Software Verification & Validation Plan (SVP)

```
1. DOCUMENT IDENTIFICATION
   Project: [EHR System Name]
   Version: 1.0
   Date: January 15, 2025
   Prepared by: Quality Assurance Team

2. PURPOSE AND SCOPE
   This document outlines the verification and validation
   strategy for [Product Name] to ensure compliance with:
   - FDA 21 CFR Part 11
   - IEC 62304 (medical device software lifecycle)
   - ONC certification requirements

3. SOFTWARE REQUIREMENTS TRACEABILITY MATRIX

   REQ-001: User Authentication
     Type: Functional
     FDA Priority: Critical
     Test Method: Automated + Manual
     Test Cases: 10
     Pass Criteria: 100% success rate
     Status: [PASS/FAIL]

4. DESIGN SPECIFICATION REVIEW
   - Architecture diagrams reviewed ✓
   - Interfaces specified ✓
   - Database design reviewed ✓
   - Security controls documented ✓

5. CODE REVIEW STANDARDS
   - Code review checklist (security focus)
   - Static analysis (SonarQube, Fortify)
   - SAST/DAST scanning
   - Peer review sign-off

6. TESTING STRATEGY
   - Unit testing: >90% code coverage
   - Integration testing: All APIs
   - System testing: All workflows
   - User acceptance testing: With clinical staff
   - Security testing: Penetration testing
   - Performance testing: Load testing

7. TEST CASE DOCUMENTATION
   [See 4.2 below]

8. RISK MANAGEMENT
   - FMEA (Failure Mode and Effects Analysis)
   - Traceability to mitigation controls
   - Post-market surveillance plan

9. CONFIGURATION MANAGEMENT
   - Version control (Git)
   - Build automation (CI/CD)
   - Release notes
   - Change log

10. SIGN-OFF
    Quality Assurance Manager: _____________ Date: _______
    Regulatory Affairs Manager: ___________ Date: _______
    Chief Medical Officer: ________________ Date: _______
```

### 4.2 Test Case Format

```
TEST CASE: TC-001 User Authentication

Objective:
Verify that users cannot access the system without valid
credentials per HIPAA §164.308(a)(5)(ii)(C)

Preconditions:
- System is operational and accessible
- Test user account disabled/reset
- Audit logging is enabled

Test Steps:
1. Navigate to https://ehr.hospital.com/login
2. Leave username field empty
3. Enter any password
4. Click "Login"

Expected Result:
- Login fails
- Error message: "Username or password incorrect"
- No audit log entry for invalid credentials

Actual Result:
[To be filled during testing]

Status: [PASS/FAIL]

Post-Condition:
- System remains operational
- Audit log contains access attempt (timestamp, IP, etc.)
- No data corrupted or leaked

Severity if Failed: CRITICAL
Test Date: January 15, 2025
Tester: QA-Smith
Sign-Off: _________________
```

---

## 5. Change Management Documentation

### 5.1 Change Control Process

```
CHANGE CONTROL BOARD (CCB) PROCESS

Step 1: CHANGE REQUEST SUBMITTED
  Form CCR-001 completed
  Description, justification, impact assessment

Step 2: INITIAL REVIEW (24 hours)
  - Is it a valid change request?
  - Are required attachments included?
  - CCB assigns priority/risk level

Step 3: IMPACT ANALYSIS
  - What modules affected?
  - Will regression testing be needed?
  - Will validation be needed?
  - Risk assessment

Step 4: CCB MEETING (weekly)
  - Review change request
  - Discuss impact
  - Risk assessment
  - Decision: Approve/Reject/Defer

Step 5: IMPLEMENTATION (if approved)
  - Development of change
  - Code review
  - Testing
  - Documentation update

Step 6: VALIDATION (if needed)
  - Regression testing
  - User acceptance testing
  - Documentation review

Step 7: DEPLOYMENT
  - Backup before change
  - Deploy to production
  - Monitor for issues
  - Rollback plan ready

Step 8: POST-IMPLEMENTATION REVIEW
  - Verify change works
  - Document lessons learned
  - Close change request
```

### 5.2 Change Documentation Template

```
CHANGE CONTROL RECORD (CCR-0247)

IDENTIFICATION:
  CCR Number: CCR-0247
  Date Submitted: 01/15/2025
  Submitter: Sarah Johnson, Pharmacy Director
  Priority: HIGH (affecting medication ordering)

DESCRIPTION:
  "Update medication reference table to include newly approved
  diabetic medication (SGLT2 inhibitor). Drug name: Empagliflozin,
  RxNorm: 401965, Strength: 10mg/25mg tablets"

BUSINESS JUSTIFICATION:
  Hospital formulary approved this medication on 1/10/2025.
  Clinicians requesting access. Delays ordering and affects
  patient care.

TECHNICAL DETAILS:
  - Database: Change to medication_master table
  - Fields: Add 2 rows (empagliflozin 10mg, 25mg)
  - UI: Add to medication dropdown (alphabetical order)
  - Tests: 4 new test cases
  - Duration: 2-3 hours development, 1 hour testing

IMPACT ASSESSMENT:
  Affected Systems: EHR ordering module, formulary database
  Risk Level: LOW (adding new medication, not modifying existing)
  Regression Testing: Required (all medication ordering workflows)
  Validation Required: YES (clinical testing)

COMPLIANCE IMPACT:
  FDA: No impact (adding to approved list)
  HIPAA: No impact (no PHI changes)
  ONC: No impact (data structure unchanged)

APPROVAL:
  Quality Assurance: _________________ Date: _______
  Regulatory Affairs: ________________ Date: _______
  Chief Pharmacist: _________________ Date: _______
  CCB Chair (CISO): _________________ Date: _______

IMPLEMENTATION:
  Status: [APPROVED/REJECTED/DEFERRED]
  Scheduled: 01/22/2025
  Implementation Notes: [deployment details]

SIGN-OFF:
  Validator: ____________________ Date: _______
  Deployment Manager: __________ Date: _______
  Post-Impl Review: __________ Date: _______
```

---

## 6. Compliance Checklist

### FDA Compliance
- [ ] Device classification determined
- [ ] 510(k) or PMA pathway identified
- [ ] Software Validation Plan (SVP) completed
- [ ] IQ/OQ/PQ testing completed
- [ ] 21 CFR Part 11 audit trails implemented
- [ ] Electronic signature controls in place
- [ ] Risk management (FMEA) documented
- [ ] Post-market surveillance plan created
- [ ] Documentation package assembled

### HIPAA Compliance
- [ ] Privacy policy written and posted
- [ ] Security risk assessment completed
- [ ] BAAs signed with all vendors
- [ ] Encryption implemented (TLS 1.2+, AES-256)
- [ ] Access controls and audit trails in place
- [ ] User authentication (MFA) implemented
- [ ] Incident response plan created
- [ ] Privacy and security training completed (100% staff)
- [ ] De-identification procedures documented

### ONC Certification Compliance
- [ ] USCDI data elements implemented
- [ ] FHIR API endpoints tested
- [ ] OAuth 2.0 authentication configured
- [ ] Structured data vocabularies (SNOMED, LOINC, RxNorm)
- [ ] CCDA export functionality tested
- [ ] Patient portal tested
- [ ] Interoperability testing completed
- [ ] API documentation provided
- [ ] Certification test results obtained

---

## 7. References and Resources

### FDA Guidance Documents
- "Software Validation: Establishing a Framework" (2002)
- "IEC 62304 Software Lifecycle Processes" (2006)
- "SaMD Clinical Evaluation" (2017)
- "Artificial Intelligence in Software as a Medical Device" (2019)

### HIPAA Standards
- 45 CFR 164.100-164.316 (HIPAA Security Rule)
- 45 CFR 164.400-414 (HIPAA Breach Notification)
- https://www.hhs.gov/hipaa/

### ONC Certification
- 45 CFR 170.315 (Certification Criteria)
- 45 CFR 170.405 (API Requirements)
- https://www.healthit.gov/certification/

### Industry Standards
- IEC 62304 (Medical Device Software Lifecycle)
- IEC 14971 (Risk Management)
- ISO 13485 (Quality Management)

---

**Version**: 1.0
**Last Updated**: 2025-11-19
**Compliance Level**: FDA Class II/III, HIPAA, ONC Certified
